Publication

Alemtuzumab treatment for steroid-refractory acute graft-versus-host disease leads to severe immunosuppression but not to relapse of malignant disease.

Journal Paper/Review - Nov 6, 2023

Philippen Lennart, Schub Natalie, Günther Andreas, Cario Gunnar, Schrappe Martin, Repp Roland, Gramatzki Martin